These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 25241610)
1. Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome. Eren E; Abuhandan M; Solmaz A; Taşkın A J Clin Res Pediatr Endocrinol; 2014 Sep; 6(3):163-8. PubMed ID: 25241610 [TBL] [Abstract][Full Text] [Related]
2. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis. Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350 [TBL] [Abstract][Full Text] [Related]
3. Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation. Tabur S; Torun AN; Sabuncu T; Turan MN; Celik H; Ocak AR; Aksoy N Eur J Endocrinol; 2010 Mar; 162(3):535-41. PubMed ID: 20022940 [TBL] [Abstract][Full Text] [Related]
4. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents. Torun E; Gökçe S; Ozgen İT; Aydın S; Cesur Y J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):667-75. PubMed ID: 24706428 [TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis. Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169 [TBL] [Abstract][Full Text] [Related]
6. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease. Kirbas A; Kirbas S; Cure MC; Tufekci A J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052 [TBL] [Abstract][Full Text] [Related]
7. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome. Ferré N; Feliu A; García-Heredia A; Marsillach J; París N; Zaragoza-Jordana M; Mackness B; Mackness M; Escribano J; Closa-Monasterolo R; Joven J; Camps J Clin Biochem; 2013 Dec; 46(18):1830-6. PubMed ID: 24028901 [TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp. Hao W; Zhu Y; Meng L; Ni C; Yang J; Zhou H Eur Arch Otorhinolaryngol; 2013 May; 270(6):1861-5. PubMed ID: 23238704 [TBL] [Abstract][Full Text] [Related]
9. Oxidative status and serum PON1 activity in beta-thalassemia minor. Selek S; Aslan M; Horoz M; Gur M; Erel O Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173 [TBL] [Abstract][Full Text] [Related]
10. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered. Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696 [TBL] [Abstract][Full Text] [Related]
11. Serum oxidative stress parameters and paraoxonase-1 in children and adolescents exposed to passive smoking. Kahraman FU; Torun E; Osmanoğlu NK; Oruçlu S; Özer ÖF Pediatr Int; 2017 Jan; 59(1):68-73. PubMed ID: 27337344 [TBL] [Abstract][Full Text] [Related]
12. Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy. Koksal H; Kurban S Clinics (Sao Paulo); 2010 Mar; 65(3):285-90. PubMed ID: 20360919 [TBL] [Abstract][Full Text] [Related]
13. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers. Gur M; Yildiz A; Demirbag R; Yilmaz R; Aslan M; Ozdogru I; Erel O Coron Artery Dis; 2007 Mar; 18(2):89-95. PubMed ID: 17301599 [TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata. Dizen-Namdar N; Emel Kocak F; Kidir M; Sarici G; Tak H; Altuntas I Skin Pharmacol Physiol; 2019; 32(2):59-64. PubMed ID: 30544126 [TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome. Usta M; Turan E; Aral H; Inal BB; Gurel MS; Guvenen G J Clin Lab Anal; 2011; 25(4):289-95. PubMed ID: 21786331 [TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia. Liang B; Li YH; Kong H Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2517-22. PubMed ID: 24089233 [TBL] [Abstract][Full Text] [Related]
18. Increased placental growth factor (PlGF) concentrations in children and adolescents with obesity and the metabolic syndrome. Pervanidou P; Chouliaras G; Akalestos A; Bastaki D; Apostolakou F; Papassotiriou I; Chrousos GP Hormones (Athens); 2014; 13(3):369-74. PubMed ID: 25079461 [TBL] [Abstract][Full Text] [Related]
19. Blood and semen paraoxonase-arylesterase activities in normozoospermic and azoospermic men. Gulum M; Gumus K; Yeni E; Dogantekin E; Ciftci H; Akin Y; Savas M; Altunkol A Andrologia; 2017 Nov; 49(9):. PubMed ID: 28000956 [TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and severity of coronary artery disease in young smokers with acute myocardial infarction. Aksoy S; Cam N; Gurkan U; Oz D; Özden K; Altay S; Durmus G; Agirbasli M Cardiol J; 2012; 19(4):381-6. PubMed ID: 22825899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]